CID 166560233

Zidesamtinib

Structural Information

Molecular Formula
C22H22FN7O
SMILES
CCN1C2=C(CC3=NN(N=C3C4=C(C=C(C=C4)F)[C@H](OC5=C(N=CC2=C5)N)C)C)C=N1
InChI
InChI=1S/C22H22FN7O/c1-4-30-21-13(11-26-30)7-18-20(28-29(3)27-18)16-6-5-15(23)9-17(16)12(2)31-19-8-14(21)10-25-22(19)24/h5-6,8-12H,4,7H2,1-3H3,(H2,24,25)/t12-/m1/s1
InChIKey
DTWUUAFTYSMNQX-GFCCVEGCSA-N
Compound name
(19R)-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,9,10,11,23-hexazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(25),2(6),4,8,11,13(18),14,16,21,23-decaen-22-amine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

2
Patents

419.18698 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 420.19426 201.8
[M+Na]+ 442.17620 215.3
[M-H]- 418.17970 200.2
[M+NH4]+ 437.22080 208.7
[M+K]+ 458.15014 209.0
[M+H-H2O]+ 402.18424 194.1
[M+HCOO]- 464.18518 212.6
[M+CH3COO]- 478.20083 209.3
[M+Na-2H]- 440.16165 201.8
[M]+ 419.18643 204.6
[M]- 419.18753 204.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe